Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Disposition and Metabolism of 2,6-DimethylbenzamideN-(5-Methyl-3-isoxazolyl) (D2916) in Male and Female Rats

J. C. Maurizis, J. C. Madelmont, M. Rapp, C. Marijnen, M. C. Cerf, J. M. Gillardin, F. Lepage and A. Veyre
Drug Metabolism and Disposition January 1997, 25 (1) 33-39;
J. C. Maurizis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. C. Madelmont
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Rapp
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Marijnen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. C. Cerf
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. M. Gillardin
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. Lepage
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Veyre
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Disposition and metabolism of the new anticonvulsant 2,6-dimethylbenzamide N-(5-methyl-3-isoxazolyl) (D2916) was studied in male and female rats after oral administration of14C-labeled material. D2916 was well absorbed in both sexes and distributed to all tissues, with maximal drug concentrations found in elimination and metabolization organs, as well as in fatty tissues. Striking differences in pharmacokinetic parameters of total radioactivity were observed between males and females: females had higher brain concentrations and longer blood and tissue half-lives. The study of blood, bile, urine, and brain metabolites showed that D2916 follows two degradation pathways related to hydroxylation of methyl groups. Males prefer to hydroxylate one of the methyl groups of the phenyl ring, and females prefer to hydroxylate the methyl of the isoxazolyl ring forming the active metabolite D3187. These findings suggest a sex difference in the location of the hydroxylation of the D2916 molecule and can explain the longer anticonvulsant effect observed in the female rat that is related both to an orientation of the metabolism toward the formation of the active metabolite and to a better ability to this metabolite to cross the blood-brain barrier, compared with the unchanged drug.

Footnotes

  • Send reprint requests to: Dr. J. C. Maurizis, Unité INSERM U71, Rue Montalembert, BP 184, 63005 Clermont-Ferrand, Cedex 1, France.

  • Abbreviations used are::
    D2916
    2,6-dimethylbenzamide N-(5-methyl-3-isoxazolyl)
    MES
    maximal electroshock
    D3187
    2,6-dimethylbenzamideN-(5-hydroxymethyl-3-isoxazolyl)
    D3269
    3-(2,6-dimethylbenzoylamino)-5-isoxazolecarboxylic acid
    D3342
    7-methyl-1(3H)-isofuranone
    D3389
    7-hydroxymethyl-1(3H)-isofuranone
    t1/2
    elimination half-life
    AUC
    area under the curve
    • Received February 19, 1996.
    • Accepted September 26, 1996.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

 

DMD articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition
Vol. 25, Issue 1
1 Jan 1997
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Disposition and Metabolism of 2,6-DimethylbenzamideN-(5-Methyl-3-isoxazolyl) (D2916) in Male and Female Rats
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Disposition and Metabolism of 2,6-DimethylbenzamideN-(5-Methyl-3-isoxazolyl) (D2916) in Male and Female Rats

J. C. Maurizis, J. C. Madelmont, M. Rapp, C. Marijnen, M. C. Cerf, J. M. Gillardin, F. Lepage and A. Veyre
Drug Metabolism and Disposition January 1, 1997, 25 (1) 33-39;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Disposition and Metabolism of 2,6-DimethylbenzamideN-(5-Methyl-3-isoxazolyl) (D2916) in Male and Female Rats

J. C. Maurizis, J. C. Madelmont, M. Rapp, C. Marijnen, M. C. Cerf, J. M. Gillardin, F. Lepage and A. Veyre
Drug Metabolism and Disposition January 1, 1997, 25 (1) 33-39;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • A PBPK model for CBD in adults and children
  • Mass Balance Recovery and Disposition of AZD4831 in Humans
  • Biotransformation of AZD4831 in Animals and Humans
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics